Australia's largest stock trading and investment forum Australia's #1 stock forum

PER

Click for more information

1.18%

8.4¢ percheron therapeutics limited

Ann: Intention to launch Share Purchase Plan, page-73

First 73 Last

Share
Profile

Follow
itsagas

13,095 Posts.

1367

26/07/23

09:01

Post #: 68982126
Share

Originally posted by waynesworld: ↑

This year there was a huge shift towards the downstream effects and in particular Inflammation, with emphasis on combination therapies@George1972

There are a number of possibilities to explain a perceived shift in tone from gene therapy to combination therapy. One explanation is that clinicians, PPMD and patient families who have invested heavily in gene therapy are moving on to ask how do we make it work.

The science is compelling - inflammation is the next battleground.

Whereas it was previously difficult to be heard above the buzz that micro-dystrophin may be a cure, three factors support the ANP story as we move forward. Firstly, ATL1102 is back in the clinic in what could potentially be a registration trial. Secondly, combination data from a mouse model is being scrutinized to confirm or dispel the thesis that ATL1102 works synergistically with dystrophin replacement therapies. Thirdly, the hope that a point will soon be reached where steroid therapies may no longer be necessary.

Expand

it really makes me happy after all these years , people on this thread are providing excellent posts Re the Science and not posting negative narratives relating to the elected Board.
Spot on Waynesworld

ANP Price at posting: 5.4¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

STN

Saturn’s stars have aligned for the gold explorer’s Apollo Project

Week 27 Wrap: "Election year" is here as UK Labour win contrasts France; Trump wins immunity & annual report season hushes ASX

ITM

Fast-track assaying yields 182 g/t gold for iTech at new NT play

LLL

Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

There are more pages in this discussion • 3 more messages in this thread...

First 73 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.4¢		Change -0.001(1.18%)		Mkt cap ! $75.72M

Open	High	Low	Value	Volume
8.4¢	8.4¢	8.3¢	$3.097K	37.23K

Buyers (Bids)

No.	Vol.	Price($)
1	29206	8.3¢

Sellers (Offers)

Price($)	Vol.	No.
8.4¢	118557	1

View Market Depth

No.	Vol.	Price($)
1	29206	0.083
2	30500	0.082
2	58100	0.081
2	160300	0.080
1	100000	0.079

Price($)	Vol.	No.
0.084	118557	1
0.085	98557	2
0.086	6500	1
0.089	135000	2
0.090	386175	4

Last trade - 16.10pm 05/07/2024 (20 minute delay)

PER (ASX) Chart